The Role of the Gut Microbiome in Antibiotic Resistance and Therapy: Mechanisms and Implications
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotic Therapy in Infectious Diseases".
Deadline for manuscript submissions: 15 October 2025 | Viewed by 38
Special Issue Editor
Interests: microbiology; antibiotics; microbiome; sequencing; fluoroquinolones; colistin; Klebsiella pneumoniae; animal models
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue addresses the complex relationship between the gut microbiome, antibiotic resistance and therapy.
Antibiotics, although essential in the treatment of bacterial infections, can significantly disrupt the gut microbiome, reducing microbial diversity by eliminating beneficial bacteria along with harmful pathogens, allowing opportunistic and resistant strains of bacteria to proliferate. The gut microbiome acts as a reservoir of antibiotic resistance genes, facilitating their horizontal transfer between bacterial species, which contributes to the spread of multidrug-resistant pathogens. In contrast, beneficial commensal bacteria can reduce resistance through mechanisms such as competitive exclusion and colonization resistance, where they outcompete pathogens for resources and produce antimicrobial compounds.
The gut microbiome acts as a reservoir of antibiotic resistance genes, facilitating their horizontal transfer between bacterial species, allowing the spread of multidrug-resistant pathogens. Antibiotic therapy disrupts the gut microbiome by killing not only harmful bacteria but also beneficial microbes, leading to a loss of microbial diversity. This disruption weakens the gut’s natural defenses, allowing opportunistic and antibiotic-resistant bacteria to thrive. Resistant strains can multiply, making infections more difficult to treat.
Recent advances in metagenomics and metabolomics offer personalized antibiotic treatment strategies that minimize collateral damage to beneficial bacteria. Adjunctive therapies such as probiotics and prebiotics hold promise in restoring gut balance and alleviating the side effects of antibiotics. Understanding these mechanisms is key to developing new therapeutic approaches to combat antibiotic resistance and preserve the efficacy of existing antibiotics.
Prof. Dr. Dóra Szabó
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gut microbiome
- antibiotic resistance
- antibiotic therapy
- pre- and probiotics
- horizontal gene transfer
- ESBL-producing enterobacterales
- Carbapenem-resistant enterobacterales
- intestinal colonization
- clostrioides difficile
- fecal microbiota transplantation (FMT)
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
